Advances in systemic therapy for metastatic breast cancer: future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in systemic therapy for metastatic breast cancer: future perspectives

Published:2017-05-19 Issue:7 Volume:34 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Corona S. P.,Sobhani N.,Ianza A.,Roviello G.,Mustacchi G.,Bortul M.,Zanconati F.,Generali D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-017-0975-5/fulltext.html

Reference145 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA. Cancer J Clin. 2016. http://www.ncbi.nlm.nih.gov/pubmed/28055103 .

2. Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R, et al. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol. 2001;19:343–53. http://www.ncbi.nlm.nih.gov/pubmed/11208825 .

3. Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. Comprehensive molecular portraits of human breast tumours. Nature. Nature Research; 2012;490:61–70. http://www.nature.com/doifinder/10.1038/nature11412 .

4. Dunnwald LK, Rossing M, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007;9:R6. http://www.ncbi.nlm.nih.gov/pubmed/17239243 .

5. Buzdar AU. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group. J Clin Oncol. 2004;22:3199-200-1. http://www.jco.org/cgi/doi/10.1200/JCO.2004.99.058 .

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review;Medicine;2024-05-03

2. MYC and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing;Medicine;2024-05-03

3. Immunomodulatory Effects of MDA-MB-231-derived Exosome Mimetic Nanovesicles on CD4+ T Cell Line;Eurasian Journal of Medicine and Oncology;2024

4. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway;BMC Cancer;2023-12-08

5. Cancer management during the COVID-19 world pandemic;Cancer Immunology, Immunotherapy;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3